• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    РМЖ: Медицинское обозрение

    РМЖ: Медицинское обозрение

    JournalISSN 2587-6821eISSN 2686-9918

    年发文量

    研究主题

    论文(738)

    排序
    1Cardiovascular Risk Factors and Their Association with Geriatric Syndromes in a Cohort of Long-Lived Individuals
    E.S. Koniaeva, L.V. Machekhina, A.A. Mamchur, V.V. Daniel, D.A. Kashtanova, A.A. Melnitskaya, Y.S. Bolashova, L.V. Maytesyan, A.I. Dudinova, I.V. Tarasova, A.A. Kubrikova, V.M. Bezrukov,

    Aim: to analyze the association between cardiovascular risk factors (CVRFs) and geriatric syndromes in a cohort of Russian longlived individuals. Materials and Methods: longlived individuals residing in the Central Federal District of the Russian Federation were enrolled in the study. Each participant underwent a physicianled comprehensive geriatric assessment, including medical history taking, physical examination, anthropometry, and functional testing, as well as laboratory evaluation of carbohydrate and lipid metabolism parameters. Results: a total of 1,373 longlived individuals were included in the study; the mean age was 92.46±2.44 years. Hypertension, abdominal obesity, and hypercholesterolemia were highly prevalent in the study cohort. Multivariable logistic regression analysis demonstrated that, among all cardiovascular risk factors examined, abdominal obesity was associated with an increased likelihood of frailty, whereas obesity defined by body mass index (BMI) was associated with an increased likelihood of sarcopenia. Inverse associations were identified between hypercholesterolemia and the probability of sarcopenia, as well as between hypertension and the probability of cognitive impairment (CI). The observed associations between CVRFs and geriatric syndromes were statistically significant predominantly in the subgroup of longlived individuals aged 90–94 years, whereas in the oldest age group (≥95 years), only a trend toward an inverse association between hypertension and CI persisted. Conclusion: in the present study, the majority of the cardiovascular risk factors examined were not associated with the principal geriatric syndromes. Inverse associations were observed for hypertension with respect to CI and for hypercholesterolemia with respect to frailty. Conversely, a positive association was demonstrated for abdominal obesity with frailty and for BMIdefined obesity with sarcopenia. The statistical significance of these associations was attenuated in the oldestold participants (≥95 years). KEYWORDS: longlived individuals; cardiovascular risk factors; geriatric syndromes; arterial hypertension; lipid and carbohydrate metabolism disorders; frailty; sarcopenia; cognitive impairment. FOR CITATION: Koniaeva E.S., Machekhina L.V., Mamchur A.A., Daniel V.V., Kashtanova D.A., Melnitskaya A.A., Bolashova Y.S., Maytesyan L.V., Dudinova A.I., Tarasova I.V., Kubrikova A.A., Bezrukov V.M., Yudin V.S., Keskinov A.A., Yudin S.M., Strazhesko I.D. Cardiovascular risk factors and their association with geriatric syndromes in a cohort of long-lived individuals. Russian Medical Inquiry. 2026;10(9):675–685 (in Russ.). DOI: 10.32364/2587-6821-2026-10-9-12

    2026
    引用
    AI阅读
    加入学术空间
    2Heart Failure and Chronic Kidney Disease in the Structure of Cardiovascular-Kidney-metabolic Syndrome: a Shift in Paradigm and Treatment Approaches
    S.R. Gilyarevsky, K.R. Akhmetova, M.V. Golschmidt, A.Yu. Shchedrina

    The paper is focused on a shift in approaches to treatment of heart failure (HF) and chronic kidney disease (CKD) as components of cardiovascularkidneymetabolic ( CKM) syndrome. It reviews evolution of concepts regarding the pathogenesis of heart failure with preserved ejection fraction (HFpEF) and, consequently, changing views on the role of reninangiotensin system activation in the development of this HF type. Current epidemiological data demonstrating a substantial increase in HFpEF prevalence are presented. The current classification of CKM syndrome which provides the basis for selecting background therapy at each stage of the syndrome, is described. The key role of abnormal adipose tissue in HFpEF development, as well as its important contribution to development and progression of CKD, is discussed. Significance of the bidirectional relationship between HF and CKD causing progression of both diseases is being discussed. A shift in approaches to background therapy for CKD and a place of irbesartan in the current management of patients with CKM syndrome and impaired kidney function are on the carpet. Data on the potential modification of treatment response in overweight and obese patients are presented. The findings of the I PRESERVE trial assessing irbesartan effects in patients with HFpEF, as well as the results of two pivotal irbesartan trials in patients with type 2 diabetes at high risk of CKD onset or progression, are discussed in a modern light. Data on the role of PPARγ activation in a beneficial effect of irbesartan on metabolic parameters, as well as its effects on uric acid levels in patients with hyperuricemia, are presented. KEYWORDS: cardiovascularkidneymetabolic syndrome, heart failure, chronic kidney disease, irbesartan. FOR CITATION: Gilyarevsky S.R., Akhmetova K.R., Golschmidt M.V., Shchedrina A.Yu. Heart failure and chronic kidney disease in the structure of cardiovascular-kidney-metabolic syndrome: a shift in paradigm and treatment approaches. Russian Medical Inquiry. 2026;10(9):621–628 (in Russ.). DOI: 10.32364/2587-6821-2026-10-9-5

    2026
    引用
    AI阅读
    加入学术空间
    3Clinical and Economic Feasibility of Urate-Lowering Allopurinol Therapy in Patients with Comorbidities and Asymptomatic Hyperuricemia
    V.V. Ryazhenov, E.R. Zakharochkina, D.A. Napalkov, I.O. Tachilovich

    Aim: to evaluate prevalence of asymptomatic hyperuricemia (HU) in patients of a multidisciplinary hospital, to determine its association with inpatient outcomes, and to submit a pharmacoeconomic justification for uratelowering therapy with allopurinol in patients with comorbidities and asymptomatic HU. Materials and Methods: a pharmacoeconomic analysis is based on a "cost — effectiveness" method simulating cardiovascular outcomes in patients with asymptomatic HU and a comorbid cardiovascular disease. An event tree model was developed for the costeffectiveness analysis. The model included patients with asymptomatic HU, concomitant cardiovascular diseases and risk factors as a target population. The economic feasibility of ULT was assessed for two alternative scenarios of managing patients with asymptomatic HU (scenario 1 — no ULT, scenario 2 — allopurinol administered as a part of standard therapy) on a shortterm time horizon. Results: added to the standard therapy, allopurinol led to lower expected number of cardiovascular events than that in the non ULT scenario. In particular, 21 myocardial infarctions (40 cases vs. 19 cases), 1 stroke (14 cases vs. 13 cases), 5 atrial fibrillations (9 cases vs. 5 cases), and 9 deaths from all causes (28 cases vs. 19 cases) were prevented per 1000 patients. As for venous thromboembolic complications, no differences were found between the scenarios; this corresponds to a lack of ULT effect in this outcome specific for the model. Conclusion: the values should be interpreted as evidence of potential clinical and economic feasibility of ULT with allopurinol (especially, in case of the conservative modeling scenario and clinical effect estimates). In addition, low cost of the therapy and its inclusion in the List of Vital and Essential Drugs enhance robustness of the clinical and economic conclusions in terms of practical healthcare. KEYWORDS: asymptomatic hyperuricemia, cardiovascular risks, uratelowering therapy, allopurinol, pharmacoeconomic analysis. FOR CITATION: Ryazhenov V.V., Zakharochkina E.R., Napalkov D.A., Tachilovich I.O. Clinical and economic feasibility of urate-lowering allopurinol therapy in patients with comorbidities and asymptomatic hyperuricemia. Russian Medical Inquiry. 2026;10(9):686–696 (in Russ.). DOI: 10.32364/2587-6821-2026-10-9-13

    2026
    引用
    AI阅读
    加入学术空间
    4Outcomes of Surgical Treatment of Tuberculous Empyema in Children and Adolescents
    M.V. Sinitsyn, E.Yu. Yakovleva, N.S. Stepanenko, A.V. Itskov, A.S. Bikbaev, T.A. Gazdanov

    Background: in tuberculosis patients, specific pleural involvement is associated with exudate or pus accumulation in the pleural cavity followed by empyema. Etiotropic chemotherapy used to manage empyema is characterized by limited efficacy; typically, a patient cannot be cured completely without surgical methods. To treat empyema, the pleural cavity is gradually punctured and drained. If ineffective, a surgeon removes empyema cavity walls with subsequent pleurectomy and lung decortication. Potential surgical techniques depend on a number of factors (mainly, the presence of a bronchial fistula, location and site of empyema). Tuberculous empyema (TE), especially in children, is still a challenge for thoracic surgery, and literature data on minimally invasive surgical treatment of TE in children are limited. Advanced minimally invasive technologies (videoassisted thoracic surgery, laser surgery) can improve TE treatment outcomes in children and adolescents. Aim: to evaluate efficacy of minimally invasive surgical treatment in children and adolescents with TE. Materials and Methods: 40 pediatric patients operated in 2018–2025 were enrolled in a retrospective singlecenter cohort study. The disease site, bacterial excretion and drug resistance of the pathogen were analysed. Surgical intervention types, as well as complication and mortality rates were evaluated. Results: 40 surgeries were performed in children and adolescents. All the operations were performed by minimally invasive techniques; a neodymium laser was used in 4 (10%) subjects. Complications were reported in 1 (2.5%) patient, mortality was 0%. Treatment efficacy was 97.5%. Conclusion: minimally invasive techniques demonstrate high efficacy of surgical TE treatment in children and adolescents. Timely referral of pediatric patients for surgical treatment helps to decrease injury rate of the intervention, to reduce duration of inpatient treatment and to improve functional outcomes. KEYWORDS: tuberculous empyema in children, minimally invasive surgical treatment, drug resistance. FOR CITATION: Sinitsyn M.V., Yakovleva E.Yu., Stepanenko N.S., Itskov A.V., Bikbaev A.S., Gazdanov T.A. Outcomes of surgical treatment of tuberculous empyema in children and adolescents. Russian Medical Inquiry. 2026;10(9):759–765 (in Russ.). DOI: 10.32364/2587- 6821-2026-10-9-20

    2026
    引用
    AI阅读
    加入学术空间
    5Inflammatory Phenotype of Crohn's Disease: Common and Challenging
    T.S. Fil, I.G. Bakulin, V.V. Petrenko

    Aim: to evaluate pathomorphosis of nonstricturing nonpenetrating (inflammatory) phenotype of Crohn's disease (CD) in the Russian population. Materials and Methods: a singlecenter retrospective cohort study with prospective assessment of outcomes was conducted. The selection was carried out among patients stayed in the Gastroenterology Department, North Western State Medical University named after I.I. Mechnikov, in 2019–2026. Primary medical documents confirming the history (e. g., discharge records, test results) were a prerequisite for enrollment. Medical history, as well as physical and instrumental data were evaluated. Results: among patients with an inflammatory phenotype of Crohn's disease, the onset was reported in 172 women (52.3%) and 157 men (47.7%). Subsequently, 136 (41.34%) out of 329 patients with an onset of an inflammatory phenotype of Crohn's disease demonstrated the phenotype transformation into a phenotype associated with strictures, fistulas, periproctitis, etc. 100 (30.4%) patients with mild activity and an inflammatory phenotype of Crohn's disease at onset had to underwent genetically engineered biological therapy (GEBT). In addition, it is compelling to note the discrepancy between clinical presentation and endoscopic activity of the inflammatory phenotype of Crohn's disease. In particular, an endoscopic examination revealed ulcers in 43% of patients with mild clinical activity and an inflammatory phenotype of CD. Conclusion: in terms of routine practice, it should be borne in mind that CD is disease that requires a whole range of instrumental and laboratory examination methods during diagnosis, followup care and monitoring of patients. This resulted from a common discrepancy between clinical and endoscopic activity of CD, very likely complications and subsequent transformation of the initial phenotype. Moreover, timely assessment of the CD phenotype transformation often cannot be based on physical data and requires a comprehensive set of instrumental examinations. KEYWORDS: inflammatory bowel diseases, Crohn's disease, Crohn's disease complications, inflammatory phenotype of Crohn's disease, phenotype transformation. FOR CITATION: Fil T.S., Bakulin I.G., Petrenko V.V. Inflammatory phenotype of Crohn's disease: common and challenging. Russian Medical Inquiry. 2026;10(9):636–642 (in Russ.). DOI: 10.32364/2587-6821-2026-10-9-7

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 738 篇论文

    高被引作者

    作者引用发文
    M. A. Livzan1817
    E. Yu. Ebzeeva124
    Ostroumova O D121
    E.V. Mironova121
    Olga Titova1211
    Nataliya Kuzubova129
    I.F. Krotkova121
    A. V. Gorelov115
    M. M. Fedorin115
    A. O. Zhelonkina101

    高产作者

    作者引用发文
    M. A. Livzan1817
    O. V. Gaus1013
    Olga Titova1211
    Gaydukova Inna410
    O. V. Inamova59
    Nataliya Kuzubova129
    В. И. Мазуров67
    Елена Мелехина26
    V. A. Solodkiy06
    Ekusheva Eugenia16

    相关期刊

    暂无数据
    暂无数据